Current report filing

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash Flows from Operating Activities:    
Net loss $ (65,027) $ (75,769)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 6,525 5,754
Stock-based compensation 4,228 3,430
Expense related to Common Stock warrants issued 43 905
Loss (gain) on disposal of property and equipment 10 (6)
Gain on investment, related to Make Composites, Inc.   (1,427)
Accretion of discount on investments 34 (1,443)
Net decrease (increase) in accrued interest related to marketable securities 162 (175)
Changes in operating assets and liabilities:    
Accounts receivable 2,881 (7,258)
Inventory (1,958) (962)
Prepaid expenses and other current assets 1,082 1,418
Accounts payable (5,467) (2,503)
Accrued expenses and other current liabilities 444 2,588
Customer deposits (547) 1,383
Deferred revenue (1,094) (253)
Change in right of use assets and lease liabilities, net (243) (222)
Net cash used in operating activities (58,927) (74,540)
Cash Flows from Investing Activities:    
Purchases of property and equipment (1,039) (7,030)
Purchase of marketable securities (62,810) (215,584)
Proceeds from sales and maturities of marketable securities 94,116 174,025
Cash paid for acquisition, net of cash acquired   (96)
Net cash provided by (used in) investing activities 30,267 (48,685)
Cash Flows from Financing Activities    
Proceeds from Preferred Stock issuances, net of issuance cost   159,644
Proceeds from exercise of stock options 255 606
Proceeds from PPP loan 5,379  
Repayment of PPP loan (5,379)  
Deferred financing costs paid (400)  
Net cash (used in) provided by financing activities (145) 160,250
Net (decrease) increase in cash, cash equivalents, and restricted cash (28,805) 37,025
Cash and cash equivalents at beginning of year 66,161 29,043
Restricted cash 612 612
Cash, cash equivalents, and restricted cash at end of period 37,968 66,680
Supplemental cash flow information:    
Interest paid 253 377
Noncash investing and financing activities:    
Common Stock issued for acquisitions   3,563
Additions to right of use assets and lease liabilities   86
Purchase of property and equipment included in accrued expenses and other current liabilities 79 867
Common Stock forfeited in satisfaction of note receivable   $ 249
Deferred transaction costs not yet paid included in accrued expenses and other current liabilities $ 2,341